Angelalign Technology (6699.HK) Releases 2025 Results, Clinical Excellence Fuels Global Growth Angelalign Technology has reported strong financial and operational performance for the fiscal year 2025, underscoring its continued expansion in…
Sensus Healthcare Initiates Legal Action Against SkinCure Oncology Over Alleged Contract Breach Sensus Healthcare,a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological…
Lebrikizumab provides up to four years of sustained disease control in moderate-to-severe atopic dermatitis Lebrikizumab Almirall, a global biopharmaceutical company dedicated to advancing medical dermatology, has announced encouraging long-term interim…
GE HealthCare to Lead Major EU IHI Consortium Advancing Cardio-Oncology Care The global healthcare landscape is undergoing a profound transformation, driven by rapid technological advancements and an increasing focus on…
FDA Clears Long Bridge Medical to Launch GOLDEN GATE Pivotal Trial for LensOne™ Prosthetic Capsular Bag Long Bridge Medical, Inc., a U.S.-based medical device innovator focused on advancing ophthalmic surgical…
BostonGene Showcases AI Disease Modeling at JSMO 2026 to Advance Precision Oncology BostonGene is set to highlight the capabilities of its advanced disease modeling platform at the 23rd Annual Meeting…
Kids Dental Day 2026 Date Announced, Adds Soles4Souls Partnership Kids Dental Day is set to return for its fifth annual celebration this summer, continuing its mission to improve children’s health…
Perceptive eClinical and Kayentis Partner to Deliver Integrated eCOA-IRT Solution for Streamlined Clinical Trials Perceptive eClinical, a recognized leader in Interactive Response Technology (IRT), has entered into a strategic partnership…
Fulgent Genetics finalizes $56.9 million deal to expand pathology and dermatopathology capabilities with Bako Diagnostics and StrataDx Fulgent Genetics, Inc., a technology-driven company known for its strong laboratory services platform…
C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests for Alzheimer’s Diagnosis Specialty diagnostics company C2N Diagnostics has announced a strategic…
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical…
Mobile Heartbeat’s Banyan Platform Connects Health System Staff Across the Enterprise Through Microsoft Teams Mobile Heartbeat, a proven leader in enterprise clinical communication and collaboration (CC&C), is spotlighting how its…